Subir material

Suba sus trabajos a SEDICI, para mejorar notoriamente su visibilidad e impacto

 

Mostrar el registro sencillo del ítem

dc.date.accessioned 2020-06-05T16:34:41Z
dc.date.available 2020-06-05T16:34:41Z
dc.date.issued 2018-05
dc.identifier.uri http://sedici.unlp.edu.ar/handle/10915/97602
dc.description.abstract Chagas disease is a neglected tropical disease endemic to Latin America, though migratory movements have recently spread it to other regions. Here, we have applied a cascade virtual screening campaign combining ligand- and structure-based methods. In order to find novel inhibitors of putrescine uptake in Trypanosoma cruzi, an ensemble of linear ligand-based classifiers obtained by has been applied as initial screening filter, followed by docking into a homology model of the putrescine permease TcPAT12. 1,000 individual linear classifiers were inferred from a balanced dataset. Subsequently, different schemes were tested to combine the individual classifiers: MIN operator, average ranking, average score, average voting, with MIN operator leading to the best performance. The homology model was based on the arginine/agmatine antiporter (AdiC) from Escherichia coli as template. It showed 64% coverage of the entire query sequence and it was selected based on the normalized Discrete Optimized Protein Energy parameter and the GA341 score. The modeled structure had 96% in the allowed area of Ramachandran's plot, and none of the residues located in non-allowed regions were involved in the active site of the transporter. Positivity Predictive Value surfaces were applied to optimize the score thresholds to be used in the ligand-based virtual screening step: for that purpose Positivity Predictive Value was charted as a function of putative yields of active in the range 0.001-0.010 and the Se/Sp ratio. With a focus on drug repositioning opportunities, DrugBank and Sweetlead databases were subjected to screening. Among 8 hits, cinnarizine, a drug frequently prescribed for motion sickness and balance disorder, was tested against T. cruzi epimastigotes and amastigotes, confirming its trypanocidal effects and its inhibitory effects on putrescine uptake. Furthermore, clofazimine, an antibiotic with already proven trypanocidal effects, also displayed inhibitory effects on putrescine uptake. Two other hits, meclizine and butoconazole, also displayed trypanocidal effects (in the case of meclizine, against both epimastigotes and amastigotes), without inhibiting putrescine uptake. en
dc.language en es
dc.subject Chagas disease es
dc.subject Cinnarizine es
dc.subject Drug repositioning es
dc.subject Drug repurposing es
dc.subject Positive predictive value es
dc.subject Putrescine uptake es
dc.subject Trypanosoma cruzi es
dc.subject Virtual screening es
dc.title Cascade ligand- and structure-based virtual screening to identify new trypanocidal compounds inhibiting putrescine uptake en
dc.type Articulo es
sedici.identifier.uri https://ri.conicet.gov.ar/11336/94582 es
sedici.identifier.uri https://www.frontiersin.org/article/10.3389/fcimb.2018.00173/full es
sedici.identifier.other http://dx.doi.org/10.3389/fcimb.2018.00173 es
sedici.identifier.other hdl:11336/94582 es
sedici.identifier.issn 2235-2988 es
sedici.creator.person Alberca, Lucas Nicolás es
sedici.creator.person Sbaraglini, María Laura es
sedici.creator.person Morales, Juan Francisco es
sedici.creator.person Dietrich, Roque Carlos es
sedici.creator.person Ruiz, María Daniela es
sedici.creator.person Pino Martínez, Agustina María es
sedici.creator.person Miranda, Cristian Gabriel es
sedici.creator.person Fraccaroli, Laura Virginia es
sedici.creator.person Alba Soto, Catalina Dirney es
sedici.creator.person Carrillo, Carolina es
sedici.creator.person Palestro, Pablo Hernán es
sedici.creator.person Talevi, Alan es
sedici.subject.materias Ciencias Exactas es
sedici.subject.materias Biología es
sedici.subject.materias Medicina es
sedici.description.fulltext true es
mods.originInfo.place Facultad de Ciencias Exactas es
mods.originInfo.place Laboratorio de Investigación y Desarrollo de Bioactivos es
sedici.subtype Articulo es
sedici.rights.license Creative Commons Attribution 4.0 International (CC BY 4.0)
sedici.rights.uri http://creativecommons.org/licenses/by/4.0/
sedici.description.peerReview peer-review es
sedici.relation.journalTitle Frontiers in Cellular and Infection Microbiology es
sedici.relation.journalVolumeAndIssue vol. 8 es


Descargar archivos

Este ítem aparece en la(s) siguiente(s) colección(ones)

Creative Commons Attribution 4.0 International (CC BY 4.0) Excepto donde se diga explícitamente, este item se publica bajo la siguiente licencia Creative Commons Attribution 4.0 International (CC BY 4.0)